Drug success signals a new trend. A "race-based" medication is a step toward individualized care.
D044383:Black People / Q000235:genetics; D002986:Clinical Trials as Topic; D004338:Drug Combinations; D006333:Heart Failure / Q000188:drug therapy* / Q000208:ethnology; D006801:Humans; D006830:Hydralazine / Q000627:therapeutic use*; D007548:Isosorbide Dinitrate / Q000627:therapeutic use*; D009569:Nitric Oxide / Q000627:therapeutic use; D014665:Vasodilator Agents / Q000627:therapeutic use
D004338:Drug Combinations; D014665:Vasodilator Agents; C431665:isosorbide-hydralazine combination; D006830:Hydralazine; D009569:Nitric Oxide; D007548:Isosorbide Dinitrate